| 1 (19) | F Hoffmann-La Roche * | MUL |  |
| 2 (28) | Merck * | MUL | |
| 3 (29) | AstraZeneca * | MUL | |
| 4 (35) | Samsung Corp * | MUL | |
| 5 (37) | Hoffmann-La Roche Ltd, United States | USA | |
| 6 (43) | Pfizer * | MUL | |
| 7 (45) | Genentech Inc | USA | |
| 8 (46) | GlaxoSmithKline * | MUL | |
| 9 (51) | Pfizer Inc, United States | USA | |
| 10 (54) | Merck & Co Inc, United States | USA | |
| 11 (80) | Novartis * | MUL | |
| 12 (96) | IBM United States | USA | |
| 13 (97) | Johnson & Johnson * | MUL | |
| 14 (109) | Bristol-Myers Squibb Company, United States | USA | |
| 14 (109) | Bristol-Myers Squibb Company * | MUL | |
| 16 (115) | Janssen | MUL | |
| 17 (134) | Ionis Pharmaceuticals | USA | |
| 18 (137) | IBM Research * | MUL | |
| 19 (141) | Eli Lilly * | MUL | |
| 20 (146) | Takeda Pharmaceuticals International Inc * | MUL | |
| 21 (148) | Eli Lilly and Company, United States | USA | |
| 21 (148) | GlaxoSmithKline, United States | USA | |
| 23 (166) | AstraZeneca, United Kingdom | GBR | |
| 24 (169) | Bayer * | MUL | |
| 25 (172) | Celgene Corp | USA | |
| 26 (177) | GlaxoSmithKline, United Kingdom | GBR | |
| 27 (178) | Regeneron Pharmaceuticals Inc | USA | |
| 28 (179) | Amgen * | MUL | |
| 29 (180) | Robert Bosch * | MUL | |
| 30 (183) | Amgen, USA | USA | |
| 31 (184) | Janssen Biotech Inc | USA | |
| 32 (194) | Novartis Institutes for Biomedical Research, United States | USA | |
| 33 (195) | Bayer AG, Germany | DEU | |
| 34 (197) | AbbVie * | MUL | |
| 35 (198) | AbbVie Inc, United States | USA | |
| 36 (200) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 37 (202) | AstraZeneca, United States | USA | |
| 38 (209) | AstraZeneca, Sweden | SWE | |
| 39 (235) | Takeda Pharmaceutical Co Inc, Japan | JPN | |
| 40 (236) | Sanofi * | MUL | |
| 41 (249) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 42 (256) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 42 (256) | Mitsubishi Corp * | MUL | |
| 44 (264) | Sanofi, United States | USA | |
| 45 (281) | Boehringer Ingelheim * | MUL | |
| 46 (282) | Merck KGaA, Germany | DEU | |
| 47 (290) | Gilead Sciences * | MUL | |
| 47 (290) | Gilead Sciences Inc, United States | USA | |
| 49 (326) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 50 (345) | Sumitomo Group * | MUL | |
| 51 (348) | Janssen Research & Development, LLC | BEL | |
| 52 (369) | Boehringer Ingelheim GmbH Germany | DEU | |
| 53 (393) | Novartis, Switzerland | CHE | |
| 54 (399) | GlaxoSmithKline, Belgium | BEL | |
| 55 (404) | Daiichi Sankyo Co., Ltd. * | MUL | |
| 56 (406) | Shionogi & Co Ltd | JPN | |
| 57 (411) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
| 58 (421) | UCB Pharma SA * | MUL | |
| 59 (426) | Biogen Idec, USA | USA | |
| 60 (436) | Astellas Pharma Inc | JPN | |
| 60 (436) | Novo Nordisk * | MUL | |
| 62 (440) | DowDupont * | MUL | |
| 63 (444) | Biogen Idec * | MUL | |
| 64 (447) | Novo Nordisk A/S | DNK | |
| 65 (457) | Unilever * | MUL | |
| 66 (475) | Manipal Global Education Group * | MUL | |
| 67 (478) | RTI Health Solutions | USA | |
| 68 (490) | Novartis Pharmaceuticals, United States | USA | |
| 69 (501) | Unilever, United Kingdom | GBR | |
| 70 (504) | Allergan plc * | MUL | |
| 71 (514) | Translational Research Institute | AUS | |
| 72 (526) | Boehringer Ingelheim, USA | USA | |
| 73 (538) | BASF Group * | MUL | |
| 74 (541) | Bayer Corp, USA | USA | |
| 75 (550) | BASF, Germany | DEU | |
| 75 (550) | Syngenta * | MUL | |
| 77 (558) | Pfizer Inc, United Kingdom | GBR | |
| 78 (560) | Sanofi, Germany | DEU | |
| 79 (561) | UCB Pharma SA, Brussels | BEL | |
| 80 (597) | Dow Chemical Co USA | USA | |
| 81 (600) | Dow Chemical Co | MUL | |
| 82 (603) | China State Institute of Pharmaceutical Industry | CHN | |
| 83 (637) | Procter & Gamble Co * | MUL | |
| 84 (638) | Procter & Gamble, USA | USA | |
| 85 (661) | Mitsubishi Chemical Holdings Corp | MUL | |
| 86 (705) | Johnson & Johnson, United States | USA | |
| 87 (718) | EMMES Corp | USA | |
| 88 (731) | Syngenta, United Kingdom | GBR | |
| 89 (753) | Abbott Laboratories * | MUL | |
| 90 (755) | Aramco * | MUL | |
| 90 (755) | Saudi Arabian Oil Company | SAU | |
| 92 (777) | Agilent Technologies * | MUL | |
| 93 (832) | Corteva | MUL | |
| 94 (840) | Corteva, USA | USA | |
|
